<DOC>
	<DOCNO>NCT00740246</DOCNO>
	<brief_summary>The objective study evaluate safety tolerability VIT-45 treatment Iron Deficiency Anemia</brief_summary>
	<brief_title>Safety Tolerability Intravenous VIT-45 Patients With Iron Deficiency Anemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<criteria>Subjects &gt; = 18 year age able give inform consent Historical laboratory Hgb indicative anemia within 3 month prior screen visit Screening Visit laboratory Hgb indicative anemia Screening Visit ferritin indicative iron deficiency anemia Known hypersensitivity VIT45 Previously receive VIT45 Parenteral iron 4 week prior screen Chronic serious active infection Malignancy history AST ALT great upper limit normal Anticipated need surgery initiation dialysis study Pregnant sexually active female willing use effective form birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>